نتایج جستجو برای: sublingual buprenorphine

تعداد نتایج: 6812  

Journal: :Indian journal of physiology and pharmacology 2008
Shantanu De Raka Jain Rajat Ray Anju Dhawan Sunny T Varghese

The aim of the present study was to evaluate, two different doses of sublingual buprenorphine (2 mg and 4 mg) among patients on maintenance treatment and to assess the relationship of steady state plasma level with craving. Twenty three male opioid dependent (ICD-10 DCR) subjects, were assigned to double blind randomized controlled trial of 2 and 4 mg/day doses of buprenorphine in an inpatient ...

2015
Lynn R Webster Michael D Smith Cemal Unal Andrew Finn

In developmental research, plasma buprenorphine concentrations comparable to a 2 mg buprenorphine-naloxone (BN) sublingual tablet have been achieved with a 0.75 mg dose of BN buccal film, a small, bioerodible polymer film for application to mucosal membranes. This was a randomized, double-blind, placebo-controlled, single-dose, four-period crossover study in opioid-dependent subjects with chron...

Journal: :BMC Family Practice 2004
Nicola S Oldham Nat MJ Wright Clive E Adams Laura Sheard Charlotte NE Tompkins

BACKGROUND Heroin is a synthetic opioid with an extensive illicit market leading to large numbers of people becoming addicted. Heroin users often present to community treatment services requesting detoxification and in the UK various agents are used to control symptoms of withdrawal. Dissatisfaction with methadone detoxification 8 has lead to the use of clonidine, lofexidine, buprenorphine and ...

Journal: :The American journal of drug and alcohol abuse 2007
Alexander M Ponizovsky Alexander Grinshpoon

OBJECTIVES To assess the quality of life (QoL) of heroin users starting and following 4 and 8 months of maintenance treatment program using buprenorphine vs. methadone. METHODS Participants received maintenance treatment with oral methadone or sublingual buprenorphine for the treatment of heroin dependence. Participants' QoL was measured using the Quality of Life Enjoyment and Satisfaction Qu...

Journal: :Journal of anesthesia & clinical research 2013
Sy-Yeu S Chern Rebecca Isserman Linda Chen Michael Ashburn Renyu Liu

Here we present a patient with a Type I Chiari malformation who was receiving buprenorphine for chronic pain who underwent two separate urogynecologic procedures for removal of vaginal mesh with two different pain management regimens. For the first procedure at an outside hospital, the patient's usual dose of buprenorphine (8 mg sublingual every 8 hours) was continued up through her surgery and...

Journal: :Expert review of clinical pharmacology 2017
Steven Chavoustie Michael Frost Ole Snyder Joel Owen Mona Darwish Ryan Dammerman Victoria Sanjurjo

INTRODUCTION Opioid use disorder is a chronic, relapsing disease that encompasses use of both prescription opioids and heroin and is associated with a high annual rate of overdose deaths. Medical treatment has proven more successful than placebo treatment or psychosocial intervention, and the partial µ-opioid receptor agonist and κ-opioid receptor antagonist buprenorphine is similar in efficacy...

Journal: :Addiction 1998
W Ling C Charuvastra J F Collins S Batki L S Brown P Kintaudi D R Wesson L McNicholas D J Tusel U Malkerneker J A Renner E Santos P Casadonte C Fye S Stine R I Wang D Segal

AIMS To evaluate the safety and efficacy of an 8 mg/day sublingual dose of buprenorphine in the maintenance treatment of heroin addicts by comparison with a 1 mg/day dose over a 16-week treatment period. As a secondary objective, outcomes were determined concurrently for patients treated with two other dose levels. DESIGN Patients were randomized to four dosage groups and treated double-blind...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید